Back to Agenda
SESSION 2: INTRODUCTION TO BENEFIT-RISK METHODOLOGIES
Session Chair(s)
Michael Forstner, PhD, MPH, MSc
Managing Director, Head of Pharmacoepidemiology Practice, Switzerland
- Overview of qualitative and quantitative methods
- Use of the methodology by US and EU regulators
Speaker(s)
INTRODUCTION TO BENEFIT-RISK METHODOLOGIES
Michael Forstner, PhD, MPH, MSc
Managing Director, Head of Pharmacoepidemiology Practice, Switzerland
Have an account?
